Abstract
Pulmonary hypertension is a significant predictor of mortality and morbidity among CKD patients. Prevalence of pulmonary hypertension in CKD varies from 15-60% depending on the study population and method of measuring pulmonary artery systolic pressure (PASP). 2D echocardiographic estimation of PASP is one of the non-invasive method of diagnosing pulmonary hypertension. Present study was aimed to know the prevalence and predictors of pulmonary hypertension in CKD 3b-5ND (non dialysis) patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
